Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Evaluation of Therapeutics for Advanced-Stage Heart Failure and Other Severely-Debilitating or Life-Threatening Diseases.

Prescott JS, Andrews PA, Baker RW, Bogdanffy MS, Fields FO, Keller DA, Lapadula DM, Mahoney NM, Paul DE, Platz SJ, Reese DM, Stoch SA, DeGeorge JJ.

Clin Pharmacol Ther. 2017 Aug;102(2):219-227. doi: 10.1002/cpt.730. Epub 2017 Jun 21. Review.

PMID:
28474798
2.

Advantages of a Truly Open-Access Data-Sharing Model.

Bertagnolli MM, Sartor O, Chabner BA, Rothenberg ML, Khozin S, Hugh-Jones C, Reese DM, Murphy MJ.

N Engl J Med. 2017 Mar 23;376(12):1178-1181. doi: 10.1056/NEJMsb1702054. No abstract available.

PMID:
28328337
3.

HER2-positive breast cancer: update on Breast Cancer International Research Group trials.

Nabholtz JM, Reese DM, Lindsay MA, Riva A.

Clin Breast Cancer. 2002 Oct;3 Suppl 2:S75-9. Review.

PMID:
12435291
4.

Docetaxel in the treatment of breast cancer: an update on recent studies.

Nabholtz JM, Reese DM, Lindsay MA, Riva A.

Semin Oncol. 2002 Jun;29(3 Suppl 12):28-34. Review.

PMID:
12170449
5.
6.

Combination chemotherapy for metastatic breast cancer.

Nabholtz JM, Reese DM, Lindsay MA, Riva A.

Expert Rev Anticancer Ther. 2002 Apr;2(2):169-80. Review.

PMID:
12113239
7.

Third-generation aromatase inhibitors in the treatment of advanced breast cancer.

Nabholtz JM, Reese DM.

Breast Cancer. 2001;8(4):305-9. Review. No abstract available.

PMID:
11791122
8.

Treatment options in hormone-refractory prostate cancer: current and future approaches.

Harris KA, Reese DM.

Drugs. 2001;61(15):2177-92. Review.

PMID:
11772129
9.

Docetaxel, estramustine, plus trastuzumab in patients with metastatic androgen-independent prostate cancer.

Small EJ, Bok R, Reese DM, Sudilovsky D, Frohlich M.

Semin Oncol. 2001 Aug;28(4 Suppl 15):71-6.

PMID:
11685733
10.

New agents for prostate cancer.

Reese DM.

Hematol Oncol Clin North Am. 2001 Jun;15(3):547-57. Review.

PMID:
11525296
11.

Intermittent androgen deprivation: update of cycling characteristics in patients without clinically apparent metastatic prostate cancer.

Grossfeld GD, Chaudhary UB, Reese DM, Carroll PR, Small EJ.

Urology. 2001 Aug;58(2):240-5.

PMID:
11489710
12.

HER2 protein expression and gene amplification in androgen-independent prostate cancer.

Reese DM, Small EJ, Magrane G, Waldman FM, Chew K, Sudilovsky D.

Am J Clin Pathol. 2001 Aug;116(2):234-9.

PMID:
11488070
13.

Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells.

Small EJ, Fratesi P, Reese DM, Strang G, Laus R, Peshwa MV, Valone FH.

J Clin Oncol. 2000 Dec 1;18(23):3894-903.

PMID:
11099318
14.

Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer.

Small EJ, Frohlich MW, Bok R, Shinohara K, Grossfeld G, Rozenblat Z, Kelly WK, Corry M, Reese DM.

J Clin Oncol. 2000 Nov 1;18(21):3595-603.

PMID:
11054432
15.

An update on prostate cancer research.

Small EJ, Reese DM.

Curr Opin Oncol. 2000 May;12(3):265-72. Review.

PMID:
10841200
16.

Choice of hormonal therapy for prostate cancer.

Reese DM.

Lancet. 2000 Apr 29;355(9214):1474-5. No abstract available.

PMID:
10801162
17.

Infusional floxuridine-based therapy for patients with metastatic renal cell carcinoma.

Reese DM, Corry M, Small EJ.

Cancer. 2000 Mar 15;88(6):1310-6.

PMID:
10717611
18.

New treatment strategies in advanced prostate cancer.

Small EJ, Reese DM.

Radiol Clin North Am. 2000 Jan;38(1):203-11, ix-x. Review.

PMID:
10664673
19.

Potential role of nephrectomy in the treatment of metastatic renal cell carcinoma: a retrospective analysis.

Tigrani VS, Reese DM, Small EJ, Presti JC Jr, Carroll PR.

Urology. 2000 Jan;55(1):36-40.

PMID:
10654891
20.

Hormone-refractory prostate cancer: an evolving standard of care.

Small EJ, Reese DM, Vogelzang NJ.

Semin Oncol. 1999 Oct;26(5 Suppl 17):61-7. Review.

PMID:
10604272
21.

Therapy of advanced prostate cancer with granulocyte macrophage colony-stimulating factor.

Small EJ, Reese DM, Um B, Whisenant S, Dixon SC, Figg WD.

Clin Cancer Res. 1999 Jul;5(7):1738-44.

22.

A phase II trial of irinotecan in hormone-refractory prostate cancer.

Reese DM, Tchekmedyian S, Chapman Y, Prager D, Rosen PJ.

Invest New Drugs. 1998-1999;16(4):353-9.

PMID:
10426671
23.

Secondary hormonal manipulations in hormone refractory prostate cancer.

Reese DM, Small EJ.

Urol Clin North Am. 1999 May;26(2):311-21, viii. Review.

PMID:
10361554
24.

Restoring the literary to medical writing.

Reese DM.

Lancet. 1999 Feb 13;353(9152):585-6. No abstract available.

PMID:
10029001
25.

Fundamentals--Rudolf Virchow and modern medicine.

Reese DM.

West J Med. 1998 Aug;169(2):105-8.

26.

Undetectable serum prostate-specific antigen associated with metastatic prostate cancer: a case report and review of the literature.

Safa AA, Reese DM, Carter DM, Phillipson J, Smith R, Dougherty S.

Am J Clin Oncol. 1998 Aug;21(4):323-6.

PMID:
9708626
27.

Oncogenic osteomalacia associated with prostate cancer.

Reese DM, Rosen PJ.

J Urol. 1997 Sep;158(3 Pt 1):887. No abstract available.

PMID:
9258108
28.

Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta11b.

Wilson CA, Payton MN, Elliott GS, Buaas FW, Cajulis EE, Grosshans D, Ramos L, Reese DM, Slamon DJ, Calzone FJ.

Oncogene. 1997 Jan 9;14(1):1-16.

29.

HER-2/neu signal transduction in human breast and ovarian cancer.

Reese DM, Slamon DJ.

Stem Cells. 1997;15(1):1-8. Review.

30.

BRCA1 protein products: antibody specificity...

Wilson CA, Payton MN, Pekar SK, Zhang K, Pacifici RE, Gudas JL, Thukral S, Calzone FJ, Reese DM, Slamon DI.

Nat Genet. 1996 Jul;13(3):264-5. No abstract available.

PMID:
8673120
31.

Anticancer drugs.

Reese DM.

Nature. 1995 Dec 7;378(6557):532. No abstract available.

PMID:
8524372
32.

HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.

Pietras RJ, Arboleda J, Reese DM, Wongvipat N, Pegram MD, Ramos L, Gorman CM, Parker MG, Sliwkowski MX, Slamon DJ.

Oncogene. 1995 Jun 15;10(12):2435-46.

PMID:
7784095

Supplemental Content

Loading ...
Support Center